Funder: Dept. of the Army -- USAMRAA

Due Dates: Forecasted; no formal deadline—currently requesting feedback on approach

Funding Amounts: Award size and total funding not specified; cost sharing required; milestone-based payments anticipated

Summary: The Army seeks feedback from research teams on a potential agreement to accelerate clinical trials of therapies for neurofibromatosis (NF1, NF2, schwannomatosis), with requirements for cost sharing and industry partnership.

Key Information: This is not a solicitation; responses are for planning and feedback only, not formal proposals.